Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study.

Regarding HOMA-IR, SVR patients with baseline IR had a decreasing trend from 12 weeks to 72 weeks after therapy.

also in 47,180 other papers

SVR patients with baseline IR had an increasing trend in BMI from 12 weeks to 72 weeks after therapy, after which their BMI remained steady, while SVR patients without baseline IR did not have an increasing trend until 48 weeks after therapy ( Figure 4 A, Table S5 ).

also in 63,971 other papers